Jonathan Friedberg, MD, Hematology, Rochester, NY, Highland Hospital

JonathanW.FriedbergMDM.M.Sc.

Hematology Rochester, NY

Director of the James P. Wilmot Cancer Institute, and Director of Hematological Malignancies Clinical Researc

Dr. Friedberg is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Friedberg's full profile

Already have an account?

  • Office

    601 Elmwood Ave Box 704
    James P Wilmot Cancer Ctr
    Rochester, NY 14642
    Phone(585) 275-4911
    Fax(585) 276-2743
  • Is this information wrong?

Education & Training

  • Dana-Farber Cancer InstituteFellowship, Hematology/Oncology, 1997 - 2000
  • Brigham and Women's Hospital
    Brigham and Women's HospitalFellowship, Hematology/Oncology, 1997 - 1999
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 1994 - 1997
  • Harvard Medical School
    Harvard Medical SchoolClass of 1994

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2002 - 2022
  • American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
  • Top MD Consumers Checkbook

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • CALBG 50604: Risk-Adapted Treatment of Non-Bulky Early Stage Hodgkin Lymphoma Based on Interim PET  
    David J Straus, Heiko Schoder, Bruce D Cheson, John C Grecula, Lale Kostakoglu, Eric D Hsi, Leslie L Popplewell, John P Leonard, Craig H Moskowitz, Brad S Kahl, Jonath..., Blood

Abstracts/Posters

  • Utility and Patterns of Use of PET/CT and Bone Marrow Biopsy for Staging in Non-Hodgkin Lymphoma in the Clinical Setting: A Retrospective Analysis Using the LEO Database
    Jonathan W. Friedberg, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • A Phase 1/2 Study of Umbralisib Ublituximab and Venetoclax in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
    Jonathan W. Friedberg, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Intraclonal Heterogeneity Caused By Activation-Induced Cytidine Deaminase Is Not a Prognostic Biomarker in Untreated Advanced Stage Follicular Lymphoma: An Analysis of...
    onathan W. Friedberg, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Lectures

  • Indolent Lymphoma and Vitamin D (ILyAD): A Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Supplemental Effect of Vitamin D on Event-Free Survival i... 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Featured Topic: Novel Therapies and Taxonomy in Lymphoid Neoplasms: Are We Ready for the Shift? 
    60th American Society of Hematology Annual Meeting - 12/2/2018
  • The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study Reflects the Demographics and Subtypes of Patients Diagnosed with Non-Hodgkin Lymphoma in the United States 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Join now to see all

Press Mentions

  • UR Awarded $29 Million for National Leadership in Cancer Control Research
    UR Awarded $29 Million for National Leadership in Cancer Control ResearchSeptember 30th, 2019
  • Dr. Oz Reveals His Mom Has Alzheimer's but He Missed the Signs: 'I Blamed Myself'
    Dr. Oz Reveals His Mom Has Alzheimer's but He Missed the Signs: 'I Blamed Myself'September 9th, 2019
  • Progress on a Cure for Cancer Requires Community Commitment and Action
    Progress on a Cure for Cancer Requires Community Commitment and ActionSeptember 9th, 2019
  • Join now to see all

Grant Support

  • Vitamin D and Follicular lymphomaNational Cancer Institute2017–2022

Committees

  • Member, NCI Lymphoma Steering Committee 2014 - Present
  • Chair, SWOG Lymphoma Committee 2014 - Present

Professional Memberships

Hospital Affiliations